Does the media prefer LMRI or OPCH?

In the previous week, Lumexa Imaging had 2 more articles in the media than Option Care Health. MarketBeat recorded 6 mentions for Lumexa Imaging and 4 mentions for Option Care Health. Lumexa Imaging's average media sentiment score of 0.99 beat Option Care Health's score of 0.59 indicating that Lumexa Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Option Care Health 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend LMRI or CRVL?

Lumexa Imaging presently has a consensus price target of $17.50, suggesting a potential upside of 71.40%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, research analysts plainly believe Lumexa Imaging is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lumexa Imaging 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation and earnings, LMRI or CRVL?

CorVel has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lumexa Imaging $267.73M 3.66 -$47.10M -$0.49 N/A CorVel $958.53M 3.96 $110.34M $2.25 33.04

Does the media favor LMRI or CRVL?

In the previous week, CorVel had 1 more articles in the media than Lumexa Imaging. MarketBeat recorded 7 mentions for CorVel and 6 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.99 beat CorVel's score of 0.88 indicating that Lumexa Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AVAH or LMRI?

In the previous week, Lumexa Imaging had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 6 mentions for Lumexa Imaging and 4 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 1.03 beat Lumexa Imaging's score of 0.99 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, WGS or LMRI?

GeneDx has higher revenue and earnings than Lumexa Imaging. GeneDx is trading at a lower price-to-earnings ratio than Lumexa Imaging, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GeneDx $427.54M 6.17 -$21.02M -$3.64 N/A Lumexa Imaging $267.73M 3.66 -$47.10M -$0.49 N/A

Does the media prefer WGS or LMRI?

In the previous week, GeneDx and GeneDx both had 6 articles in the media. Lumexa Imaging's average media sentiment score of 0.99 beat GeneDx's score of 0.88 indicating that Lumexa Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GeneDx 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PRVA or LMRI?

In the previous week, Lumexa Imaging had 1 more articles in the media than Privia Health Group. MarketBeat recorded 6 mentions for Lumexa Imaging and 5 mentions for Privia Health Group. Lumexa Imaging's average media sentiment score of 0.99 beat Privia Health Group's score of 0.65 indicating that Lumexa Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Lumexa Imaging (LMRI) Competitors

$10.21 +0.33 (+3.34%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$10.22 +0.01 (+0.06%)

As of 09/25/2026 07:30 PM Eastern

Compare

LMRI vs. OPCH, CRVL, AVAH, WGS, and PRVA

Should you buy Lumexa Imaging stock or one of its competitors? Lumexa Imaging's main competitors and comparable companies include Option Care Health (OPCH), CorVel (CRVL), Aveanna Healthcare (AVAH), GeneDx (WGS), and Privia Health Group (PRVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Lumexa Imaging compare to Option Care Health?

Lumexa Imaging (NASDAQ:LMRI) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings.

In the previous week, Lumexa Imaging had 2 more articles in the media than Option Care Health. MarketBeat recorded 6 mentions for Lumexa Imaging and 4 mentions for Option Care Health. Lumexa Imaging's average media sentiment score of 0.99 beat Option Care Health's score of 0.59 indicating that Lumexa Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Option Care Health	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Option Care Health has a net margin of 3.68% compared to Lumexa Imaging's net margin of 0.00%. Option Care Health's return on equity of 18.74% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Option Care Health	3.68%	18.74%	7.25%

Lumexa Imaging presently has a consensus price target of $17.50, suggesting a potential upside of 71.40%. Option Care Health has a consensus price target of $29.92, suggesting a potential upside of 29.71%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, research analysts clearly believe Lumexa Imaging is more favorable than Option Care Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
Option Care Health	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

98.1% of Option Care Health shares are owned by institutional investors. 0.7% of Lumexa Imaging shares are owned by company insiders. Comparatively, 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Option Care Health has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	3.66	-$47.10M	-$0.49	N/A
Option Care Health	$5.65B	0.61	$207.59M	$1.33	17.35

Summary

Option Care Health beats Lumexa Imaging on 10 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to CorVel?

Lumexa Imaging (NASDAQ:LMRI) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

CorVel has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	3.66	-$47.10M	-$0.49	N/A
CorVel	$958.53M	3.96	$110.34M	$2.25	33.04

51.4% of CorVel shares are held by institutional investors. 0.7% of Lumexa Imaging shares are held by insiders. Comparatively, 39.7% of CorVel shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, CorVel had 1 more articles in the media than Lumexa Imaging. MarketBeat recorded 7 mentions for CorVel and 6 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.99 beat CorVel's score of 0.88 indicating that Lumexa Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CorVel has a net margin of 11.72% compared to Lumexa Imaging's net margin of 0.00%. CorVel's return on equity of 29.92% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
CorVel	11.72%	29.92%	17.82%

Lumexa Imaging presently has a consensus price target of $17.50, suggesting a potential upside of 71.40%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, research analysts plainly believe Lumexa Imaging is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

CorVel beats Lumexa Imaging on 11 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to Aveanna Healthcare?

Aveanna Healthcare (NASDAQ:AVAH) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by insiders. Comparatively, 0.7% of Lumexa Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Aveanna Healthcare has a net margin of 10.56% compared to Lumexa Imaging's net margin of 0.00%. Aveanna Healthcare's return on equity of 80.70% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Lumexa Imaging	N/A	N/A	N/A

Aveanna Healthcare has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.11	$225.03M	$1.23	10.09
Lumexa Imaging	$267.73M	3.66	-$47.10M	-$0.49	N/A

Aveanna Healthcare currently has a consensus target price of $14.06, suggesting a potential upside of 13.26%. Lumexa Imaging has a consensus target price of $17.50, suggesting a potential upside of 71.40%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Lumexa Imaging had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 6 mentions for Lumexa Imaging and 4 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 1.03 beat Lumexa Imaging's score of 0.99 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Aveanna Healthcare beats Lumexa Imaging on 11 of the 15 factors compared between the two stocks.

How does Lumexa Imaging compare to GeneDx?

GeneDx (NASDAQ:WGS) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

61.7% of GeneDx shares are owned by institutional investors. 25.2% of GeneDx shares are owned by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Lumexa Imaging has a net margin of 0.00% compared to GeneDx's net margin of -23.41%. GeneDx's return on equity of 4.12% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GeneDx	-23.41%	4.12%	2.26%
Lumexa Imaging	N/A	N/A	N/A

GeneDx currently has a consensus price target of $89.57, suggesting a potential upside of 1.33%. Lumexa Imaging has a consensus price target of $17.50, suggesting a potential upside of 71.40%. Given Lumexa Imaging's higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than GeneDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GeneDx	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

GeneDx has higher revenue and earnings than Lumexa Imaging. GeneDx is trading at a lower price-to-earnings ratio than Lumexa Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GeneDx	$427.54M	6.17	-$21.02M	-$3.64	N/A
Lumexa Imaging	$267.73M	3.66	-$47.10M	-$0.49	N/A

In the previous week, GeneDx and GeneDx both had 6 articles in the media. Lumexa Imaging's average media sentiment score of 0.99 beat GeneDx's score of 0.88 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GeneDx	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

GeneDx beats Lumexa Imaging on 9 of the 14 factors compared between the two stocks.

How does Lumexa Imaging compare to Privia Health Group?

Privia Health Group (NASDAQ:PRVA) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Lumexa Imaging had 1 more articles in the media than Privia Health Group. MarketBeat recorded 6 mentions for Lumexa Imaging and 5 mentions for Privia Health Group. Lumexa Imaging's average media sentiment score of 0.99 beat Privia Health Group's score of 0.65 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Privia Health Group presently has a consensus target price of $31.00, suggesting a potential upside of 57.28%. Lumexa Imaging has a consensus target price of $17.50, suggesting a potential upside of 71.40%. Given Lumexa Imaging's higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than Privia Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

Privia Health Group has a net margin of 1.19% compared to Lumexa Imaging's net margin of 0.00%. Privia Health Group's return on equity of 3.52% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Lumexa Imaging	N/A	N/A	N/A

Privia Health Group has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.19	$22.92M	$0.21	93.86
Lumexa Imaging	$267.73M	3.66	-$47.10M	-$0.49	N/A

Summary

Privia Health Group beats Lumexa Imaging on 11 of the 16 factors compared between the two stocks.

Get Lumexa Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LMRI vs. The Competition

Export

Metric	Lumexa Imaging	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$980.93M	$9.82B	$7.34B	$13.18B
Dividend Yield	N/A	2.59%	2.52%	14.02%
P/E Ratio	-20.84	35.06	275.82	25.76
Price / Sales	3.66	5.05	610.47	82.46
Price / Cash	29.37	123.01	79.52	52.89
Price / Book	1.65	5.24	10.44	6.30
Net Income	-$47.10M	$315.70M	$3.51B	$360.35M
7 Day Performance	-7.85%	0.71%	-1.31%	-0.23%
1 Month Performance	-14.63%	-0.41%	-4.72%	-3.87%
1 Year Performance	N/A	16.63%	14.97%	5.38%

Lumexa Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LMRI Lumexa Imaging	4.25 of 5 stars	$10.21 +3.3%	$17.50 +71.4%	N/A	$980.93M	$267.73M	N/A	5,019	News Coverage Positive News Analyst Forecast
OPCH Option Care Health	3.9547 of 5 stars	$24.50 +0.1%	$29.92 +22.1%	-14.0%	$3.67B	$5.69B	18.42	8,266	Positive News Analyst Forecast High Trading Volume
CRVL CorVel	1.5809 of 5 stars	$70.50 -1.0%	N/A	-5.2%	$3.63B	$958.53M	31.33	5,239	Positive News
AVAH Aveanna Healthcare	4.5021 of 5 stars	$13.97 -2.0%	$14.06 +0.6%	+46.7%	$3.11B	$2.60B	11.36	35,500
WGS GeneDx	1.7833 of 5 stars	$104.95 +7.7%	$89.57 -14.7%	-21.7%	$2.91B	$427.54M	N/A	1,300	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LMRI) was last updated on 9/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lumexa Imaging (LMRI) Competitors

LMRI vs. OPCH, CRVL, AVAH, WGS, and PRVA

How does Lumexa Imaging compare to Option Care Health?

Summary

How does Lumexa Imaging compare to CorVel?

Summary

How does Lumexa Imaging compare to Aveanna Healthcare?

Summary

How does Lumexa Imaging compare to GeneDx?

Summary

How does Lumexa Imaging compare to Privia Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lumexa Imaging (LMRI) Competitors

LMRI vs. OPCH, CRVL, AVAH, WGS, and PRVA

How does Lumexa Imaging compare to Option Care Health?

Does the media prefer LMRI or OPCH?

Is LMRI or OPCH more profitable?

Do analysts prefer LMRI or OPCH?

Do insiders and institutionals have more ownership in LMRI or OPCH?

Which has preferable earnings and valuation, LMRI or OPCH?

Summary

How does Lumexa Imaging compare to CorVel?

Which has stronger valuation and earnings, LMRI or CRVL?

Do institutionals and insiders hold more shares of LMRI or CRVL?

Does the media favor LMRI or CRVL?

Is LMRI or CRVL more profitable?

Do analysts recommend LMRI or CRVL?

Summary

How does Lumexa Imaging compare to Aveanna Healthcare?

Do insiders & institutionals have more ownership in AVAH or LMRI?

Is AVAH or LMRI more profitable?

Which has better earnings and valuation, AVAH or LMRI?

Do analysts recommend AVAH or LMRI?

Does the media prefer AVAH or LMRI?

Summary

How does Lumexa Imaging compare to GeneDx?

Do institutionals and insiders have more ownership in WGS or LMRI?

Is WGS or LMRI more profitable?

Do analysts prefer WGS or LMRI?

Which has higher valuation and earnings, WGS or LMRI?

Does the media prefer WGS or LMRI?

Summary

How does Lumexa Imaging compare to Privia Health Group?

Do institutionals & insiders have more ownership in PRVA or LMRI?

Does the media refer more to PRVA or LMRI?

Do analysts rate PRVA or LMRI?

Is PRVA or LMRI more profitable?

Which has stronger valuation and earnings, PRVA or LMRI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools